from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1983/PE_PGRS35

LFCtreatmentdescriptionclass of inhibitor

0.368

Amikacinug/mL Amikacintranslation

1.061

Cap5-10ug/mL Capreomycintranslation

0.438

Rox10-50 ug/mL Roxithromycintranslation

-0.571

SM2-5 ug/mL Streptomycintranslation

-0.479

Tet5-10 ug/mL Tetracyclinetranslation

1.738

Rif0.2-5ug/mL Rifampicintranscription

0.358

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.023

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.346

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.006

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.230

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.165

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.641

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.249

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.195

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.392

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.500

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.116

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.263

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.585

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.165

Nigericin50 uM Nigericinrespiration

0.018

TRC10-150 ug/mL Triclosanrespiration

-0.585

TRZ10-25 ug/mL Thioridazinerespiration

-1.239

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.772

menadione6-10 ug/mL Menadionerespiration

-0.105

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.011

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.308

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.109

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.110

NRP_1Non-replicating persistence stage 1dosRassociated

-0.553

Amp0.2mg/mL AmpicillincellWall

-0.612

Cephalexin20-100 ug/mL CephalexincellWall

-0.135

Cerulenin0.32-5 ug/mL CerulenincellWall

1.970

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

2.406

EMB10-20 ug/mL EthambutolcellWall

0.690

Eta12-40 ug/mL EthionamidecellWall

0.070

INH0.2-0.4 ug/mL IsoniazidcellWall

0.384

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.533

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.368

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

0.354

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.470

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.850

H2O24 mM hydrogen peroxideDNAdamaging

-0.180

Levo10 ug/mL LevofloxacinDNAdamaging

0.204

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.208

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.081

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.360

UVUV-irradiationDNAdamaging

-0.803

ARP41-4 ug/mL Antitubercular compound ARP4?

0.163

Antimycin12.5-50 ug/mL Antimycin A?

-0.449

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.420

PA_110-50 ug/mL Antitubercular compound PA-1?

1.030

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.028

PA8240.2-2 ug/mL PA-824?

0.355

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.555

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.328

Verapamil50 uM Verapamil?

-1.057

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.320

methoxatin10-20 ug/mL Methoxatin?